SUVEN PHARMA: Q3 EBITDA RUPEES 1.47B VS 1.86B (YOY) || Q3 EBITDA MARGIN 41.47% VS 47.5% (YOY)

POOR EBITDA
POOR MARGINS
 
 
Back to Top